Wall Street Teacher (a pseudonym) worked on Wall Street for several years in the fixed income area and now teaches and writes on financial topics (primarily regulation and markets). Current interests include the psychology of financial markets, the origins of chemistry/physics, synthetic biology, human evolution,siege engines, antique prints, truffles, old cameras, debunking "short and distort" hit pieces, picking RJ Kirk's brain, Battlefield III (we all have our vices) and horology.
I'm a value investor focused on buying companies trading below the intrinsic value.
I've a back ground in engineering & finance. I'm also a Chartered Financial Analyst. I did my MBA from Emory University's Goizueta School of Business
Chris is the founder of a new Austin-based startup in the beta testing phase.
He is entrepreneur with significant experience researching and evaluating a broad spectrum of subjects, including: technology, investments and private equity opportunities.
Previously he served as Director of Marketing & Technology at Axion Capital Management / Axion Opportunity Fund. A top ranked boutique absolute return fund with a global perspective.
Besides being an Analyst on both the Buyside and Sellside, the author has worked in Corporate Strategy and Finance roles for technology services companies.
For the year 2016, the Graycell Small Cap Portfolio was up +71% compared to benchmark Russell 2000 Index gain of +19%. In addition, the Prudent Biotech Portfolio was up +7%, compared to Biotech Index (IBB) decline of -21% in 2016
For many years we have been developing quantitative models to create risk-adjusted, return-driven products. We invite you to take a look at the Graycell Advisors and Prudent Biotech websites for Samples, Performance, Philosophy, and Approach and decide for yourself if the Biotech and Small Cap products can contribute to your investment objectives.
You may even Register for a Free Pick from the Portfolio,
All subscriptions come with a Risk-free, 60-Day Money-back Guarantee.
Any questions, please write to Support @ PrudentBiotech.com or use the Contact Form.
Graycell Advisors and related entities are not a Registered Investment Advisor (RIA). Nothing here or on the site constitutes a personalized investment recommendation, and stocks mentioned in the reports/articles/comments may be now or in the past, part of the portfolios recommended by Graycell Advisors and related entities.
I am a medical professional that enjoys investing in biotech stocks. I take long positions and may dabble in options. I have a particular interest in biotechs with an ophthalmic (eye) focus as that is where I have developed the greatest expertise over my career and research. I hope over time to share some of my professional insights with those of the Seeking Alpha community in order to help them make more informed investing decisions. I expect to learn a lot from others as well.
I am long the following biotechs at this time: GILD, OPHT, CRMD, ACAD, RLYP, HALO, TGTX, APHB, ZIOP.
I am advising everyone to avoid: OHRP